Vitronectin-binding staphylococci enhance surface-associated complement activation

Infection and Immunity

Volumn 65, Issue 3, 1997, Pages 897-902

  Lundberg, Fredrik ^a   Lea, Tor ^b   Ljungh, Åsa ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; EPITOPE; VITRONECTIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIUM ADHERENCE; BINDING SITE; BLOOD CULTURE; CELL MOTILITY; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPLEMENT ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; POLYMERIZATION; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS HAEMOLYTICUS; STATISTICAL ANALYSIS;

EID: 0031038359     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.3.897-902.1997     Document Type: Article

References (47)

1. Baldassari, L. Personal communication.
2. 1a. Barbucci, R., and A. Magnani. 1994. Conformation of human plasma proteins at polymer surfaces: the effectiveness of surfaces: heparinization. Biomaterials 15:955-962.
3. Barnes, D. W., J. E. Reing, and B. Amos. 1985. Heparin-binding properties of human serum spreading factor. J. Biol. Chem. 260:9117-9122.
4. Becherer, J. D., J. Alsenz, C. Servis, B. L. Myones, and J. D. Lambris. 1989. Cell surface proteins reacting with activated complement components. Complement Inflammation 6:142-165.
5. Berger, M., Broxup, and M. V. Sefton. 1994. Using Elisa to evaluate complement activation by reference biomaterials. J. Mater. Sci. Mater. Med. 5: 622-627.
6. Clark, D. E., and T. A. Raffin. 1990. Intravenous complications of indwelling long-term central venous catheters. Chest 97:966-972.
7. Dierich, M. P. 1988. The receptors, p. 262-272. In K. Rother and G. O. Till (ed.), The complement system. Springer-Verlag, Berlin, Germany.
8. Edens, R. E., R. J. Linhardt, C. S. Bell, and J. M. Weiler. 1994. Heparin and derivatized heparin inhibit zymozan and cobra venom factor activation of complement in serum. Immunopharmacology 27:145-153.
9. Fearon, D. T., and W. W. Wong. 1983. Complement ligand-receptor interactions that mediate biological responses. Annu. Rev. Immunol. 1:243-271.
10. Gebb, C., E. G. Hayman, E. Engvall, and E. Ruoslahti. 1986. Interaction of vitronectin with collagen. J. Biol. Chem. 261:16698-16703.
11. Giese, M. J., B. J. Mondino, B. J. Glasgow, H. L. Sumner, S. A. Adamu, H. P. Halabi, and H. J. Chou. 1994. Complement system and host defense against staphylococcal endophthalmitis. Invest. Ophthalmol. Visual Sci. 35: 1026-1032.
12. Hayashi, M., T. Akama, I. Kono, and H. Kashiwagi. 1985. Activation of vitronectin (serum spreading factor) binding of heparin by denaturing agents. J. Biochem. 98:1135-1138.
13. Hayman, E. G., M. D. Pierschbacher, Y. öhgren, and E. Ruoslahti. 1983. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc. Natl. Acad. Sci. USA 80:4003-4007.
14. Kanse, S. M., C. Kost, O. G. Wilhelm, P. A. Andreasen, and K. T. Preissner. 1996. The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp. Cell Res. 224:344-353.
15. Labarre, D. J. 1990. Heparin-like polymer surfaces: control of coagulation and complement activation by insoluble functionalized polymers. Biomaterials 9:30-35.
16. Larm, O., L. Adolfsson, I. Gouda, A. Malmberg, and P. Olsson. 1987. An improved method for covalent immobilization of heparin by end-point attachment. Thromb. Haemostasis 58:84.
17. Law, S. K. A., and K. B. M. Reid. 1988. Complement. Coordinating ed., D. Male and D. Rickwood. IRL Press Limited, Oxford, England.
18. Ludwicka, A., L. M. Switalski, A. Lundin, G. Pulverer, and T. Wadström. 1985. Bioluminesccnce assay for measurement of bacterial attachment to polyethylene. J. Microbiol. Methods 4:169-177.
19. Lundberg, F., S. Schliamser, and Å. Ljungh. Vitronectin may mediate staphylococcal adhesion to polymers exposed to perfusing human cerebrospinal fluid. J. Med. Microbiol., in press.
20. 18a. Lundberg, F., J. Tegenfeldt, L. Montelius, U. Ransjö, P. Appelgren, P. Siesjö, and Å. Ljungh. Unpublished data.
21. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and nonactivators of the complement pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87: 3982-3986.
22. Mollnes, T. E., J. Riesenfeld, P. Garred, E. Nordström, K. Hogåsen, E. Fosse, O. Götzse, and M. Harboe. 1995. A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin. Artif. Org. 19:909-917.
23. Mollnes, T. E., V. Videm, J. Riesenfeld, P. Garred, J. L. Svennevid, E. Fosse, K. Hogasen, and M. Harboe. 1991. Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvements of biomaterials. Clin. Exp. Immunol. 1:21-26.
24. Mondino, B. J., S. Nagata, and M. M. Glovskv. 1985. Activation of the alternative complement pathway by intraocular lenses. Invest. Ophthalmol. Visual Sci. 26:905-908.
25. Niculescu, F., H. G. Rus, D. Porutiu, V. Ghiurca, and R. Vlaicu. 1989. Immunoelectron-microscopic localization of S-protein vitronectin in human atherosclerotic wall. Atherosclerosis 78:197-203.
26. Nilsson, H. R., K. E. Storm, H. Elwing, and B. Nilsson. 1993. Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface. Mol. Immunol. 30:211-219.
27. Nilsson-Ekdahl, K., B. Nilsson, M. Pekna, and U. R. Nilsson. 1992. Generation of iC3 at the interface between blood and gas. Scand. J. Immunol. 35:85-91.
28. Nydegger, U. E., R. Rieben, and B. Aeschbacher. 1990. Biocompatibility of apheresis harness. Transfus. Sci. 11:43-54.
29. Paulsson, M., I. Gouda, O. Larm, and Å. Ljungh. 1994. Adherence of coagulase-negative staphylococci to heparin and other glycosaminoglycans immobilized on polymer surfaces. J. Biomed. Mater. Res. 28:311-317.
30. Paulsson, M., O. D. Liang, F. Ascencio, and T. Wadström. 1992. Vitronectin-binding surface proteins of Staphvlococcus aureus. Zentrabl. Bakteriol. 277:54-56.
31. Paulsson, M., Å. Ljungh, and T. Wadström. 1992. Rapid identification of fibronectin, vitronectin, laminin and collagen cell surface binding proteins on coagulase-negative staphylococci by particle agglutination assays. J. Clin. Microbiol. 30:2006-2012.
32. Paulsson, M., and T. Wadström. 1990. Vitronectin and type-I collagen binding by Staphylococcus aureus and coagulase-negative staphylococci by particle agglutination assays. J. Clin. Microbiol. 30:2006-2012.
33. Pekna, M., R. Larsson, B. Formgren, U. R. Nilsson, and B. Nilsson. 1993. Complement activation by polymethylmethacrylate minimized by end-point heparin attachment. Biomaterials 14:189-192.
34. Pekna, M., L. Nilsson, K. Nilsson-Ekdahl, U. R. Nilsson, and B. Nilsson. 1993. Evidence for the generation of iC3 during cardiopulmonary bypass as the result of blood-gas interaction. Clin. Exp. Immunol. 91:404-409.
35. Podack, E. R., and H. J. Müller-Eberhard. 1979. Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. J. Biol. Chem. 254:9908-9914.
36. Podack, E. R., K. T. Preissner, and H. J. Müller-Eberhard. 1984. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein. APMIS Sect. C Suppl. 92:89-96.
37. Preissner, K. T. 1991. Structure and biological role of vitronectin. Annu. Rev. Cell Biol. 7:275-310.
38. Preissner, K. T., and G. Müller-Berghauser. 1985. S-protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin. III. Evidence for a direct interaction of S-protein with heparin. Eur. J. Biochem. 156:645-649.
39. Preissner, K. T., E. R. Podack, and H. J. Müller-Eberhard. 1985. The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7. J. Immunol. 135:445-451.
40. Rapoza, R., and T. A. Horbett. 1990. Postadsorptive transitions in fibrinogen: influence of polymer properties. J. Biomed. Mater. Res. 11124:1263-1287.
41. Rozalska, B., and A. Ljungh. 1995. Biomaterial-associated staphylococcal peritoneal infections in a neutropaenic mouse model. FEMS Microbiol. Lett. 11:307-320.
42. Salama, A., D. Hugo, R. Heinrich, R. Höge, R. Müller, V. Kiefel, C. Mueller-Eckhardt, and S. Bhakdi. 1988. Deposition of terminal C5H-9 complement complexes on erythrocytes and leucocytes during cardiopulmonary bypass. N. Engl. J. Med. 7:408-414.
43. Tschopp, J., D. Masson, S. Schafer, M. Peitsch, and K. T. Preissner. 1988. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perform from cytolytic T-cells and inhibits their lytic activities. Biochemistry 31:4103-4109.
44. van Wamel, W. J., A. C. Fluit, T. Wadström, H. van Dijk, J. Verhoef, and M. J. E. C. Vandenbroucke-Grauls. 1995. Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 33:1769-1774.
45. Yatohgo, T., M. Izumi, H. Kashiwagi, and M. Hayashi. 1988. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 13:281-292.
46. Yu, J., M. Nordman-Montelius, M. Paulsson, I. Gouda, O. Larm, L. Montelius, and A. Ljungh. 1994. Adhesion of coagulase-negative staphylococci and adsorption of plasma proteins to heparinized polymer surfaces. Biomaterials 15:805-814.
47. Zhuang, P., H. Li, J. G. Williams, N. V. Wagner, D. Seiffert, and C. B. Peterson. 1996. Characterization of the denaturation and renaturation of human plasma vitronectin. J. Biol. Chem. 271:14333-14343.